September 18, 2018

GSK will sell Romanian plant

The UK-based pharmaceuticals group, GlaxoSmithKline (GSK), excluded its plant in Brasov from the global production chain citing over-production for solid oral formulas. The group will seek a buyer for the facility in the next six months. If a buyer is not found, the company will move its production to other plants, close its local facility and fire all the staff. This decision would be enforced by the second half of 2015, the latest. According to GSK, the Brasov plant hasn’t been used at full capacity and there isn’t any long term growth potential to manufacture new products here. The company said it hadn’t found a realistic and financially sustainable solution to secure its survival. Pascal Prigent, general director GSK Romania, said the decision doesn’t have anything to do with the performance of the Brasov plant. “The decision came following a wave of expired patents that lead to an excess of capacities in solid oral formulas,” said Prigent. Also he said the company will continue to invest between EUR 8 to 10 million for research and development in the next five years.

Source: Business-Review () I look at 5-7 students’ work and feel so proud that their outlines are detailed, write essays for me meticulous, and clearly structured

Speak Your Mind


Click on the picture to try another code*

Click on the picture to try another code

Powered by: